Navigation Links
Lupin Launches Ramipril Capsules
Date:6/11/2008

ange of quality, affordable generic and branded formulations and APIs for the developed and developing markets of the world. The Company has secured global leadership position in Anti-TB and Cephalosporins and has a significant presence in the areas of Cardiovasculars (prils and statins), Diabetology, Asthma and NSAIDs.

The Company's R&D endeavors have resulted in significant progress in its NCE program. The Company's foray into New Drug Delivery Systems has resulted in the development of platform technologies that are being used to develop value-added generic pharmaceuticals.

For the financial year ended March 2008, the Lupin's Revenues and Profit after Tax were Rs.27,730 million (US$ 694 million) and Rs.4,083 million (US$ 102 million) respectively.

Lupin Pharmaceuticals, Inc. (LPI) is the U.S. wholly owned subsidiary of Lupin Limited, which is among the top six Pharmaceutical companies in India. Through its sales and marketing headquarters in Baltimore, Maryland, Lupin Pharmaceuticals, Inc. is dedicated to delivering high-quality, affordable generic medicines trusted by healthcare professionals and patients across geographies. For more information, visit http://www.lupinpharmaceuticals.com.

Safe Harbor Statement under the U. S. Private Securities Litigation Reform Act of 1995:

This release contains forward-looking statements that involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. Many of these risks, uncertainties and other factors include failure of clinical trials, delays in development, registration and product approvals, changes in the competitive environment, increased government control over pricing, fluctuations in the capital and foreign exchange markets and the ability to maintain patent and othe
'/>"/>

SOURCE Lupin Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Lupin Receives USFDA Approval for Topiramate Tablets
2. CVS Caremark Launches the 2008 Season of the CVS Caremark All Kids Can(TM) Baseball Camps at Fenway Park
3. Miami Institute Launches New Weight Loss Program
4. PointOne Launches New Business Direction, Healthcare Analytics Beyond Hospitals
5. WellPoint Launches and Expands Maternity Depression Program
6. Nutrition 21 Launches Iceland Health(R) Advanced Memory Formula via Direct Response Channel
7. Video: The Nevada Division of Insurance Launches 2008 Health Sham Insurance Campaign
8. Princeton HealthCare System Foundation Launches $115 Million Capital Campaign for New Hospital in New Jersey
9. Cline Davis & Mann Launches Platform Advisors(TM), a New Division to Provide Integrated Strategic and Scientific Consulting Services for the Pharmaceutical, Biotechnology, and Medical Device Industry
10. AVMA Launches Animal Welfare Web Section to Provide Hub for Programs and Information
11. US Oncology Launches Oncology-Specific Billing and Reimbursement Service
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2014)... key genes linked to why some people have a ... study released today that will be presented at the ... April 26 to May 3, 2014. , "Our ... way to understand pain and why different individuals have ... MD, MPH, with Proove Biosciences and a member of ...
(Date:4/18/2014)... Harvard neuroscientists have made a discovery that turns 160 ... electrical insulating material long known to be essential for ... nerve cells, is not as ubiquitous as thought, according ... of the Harvard Stem Cell Institute (HSCI) and the ... collaboration with Professor Jeff Lichtman, of Harvard,s Department of ...
(Date:4/18/2014)... A new study in the American Journal of ... searches reveals a recurring pattern that could be leveraged ... from San Diego State University, the Santa Fe Institute, ... Google searches (searches that included the term healthy and ... U.S. from 2005 to 2012. They found that on ...
(Date:4/17/2014)... first genetic variant specifically associated with the risk ... 10-15 per cent of all breast cancer cases. ... cancer sub-type, called invasive lobular carcinoma, gives researchers ... particular kind of breast cancer, which can be ... (Thursday) in the journal PloS Genetics , ...
(Date:4/17/2014)... California, San Diego School of Medicine report that older ... recent major loss are more likely to be compassionate ... is published in this month,s issue of the ... behaviors are associated with better health and well-being as ... to improve the outcomes of individuals whose deficits in ...
Breaking Medicine News(10 mins):Health News:Low tolerance for pain? The reason may be in your genes 2Health News:Finding turns neuroanatomy on its head 2Health News:Finding turns neuroanatomy on its head 3Health News:New research shows people are thinking about their health early in the week 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 3Health News:The ilk of human kindness 2
... Cancer researchers have discovered a previously unknown type of ... that may lead to better insight about environmental exposure ... the journal Genome Research by researchers at ... Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James), ...
... In a promising development for cancer patients in New ... at Hackensack University Medical Center announced today that it ... to acquire an innovative system that enables a radically ... known as the TrueBeam system. The new radiotherapy system ...
... the 2008-09 Gaza War gave Tel Aviv University researchers a ... In a new study in the American Journal ... of Psychology reports that people confronted with acute stress -- ... of becoming more vigilant. This research overturns accepted convention and ...
... HealthDay Reporter , FRIDAY, July 16 (HealthDay News) -- High ... cost of wearing them is even steeper than the sky-high ... aching feet and a variety of foot deformities, years of ... muscles and tendons, according to a study by researchers in ...
... Institute of Technology not only involves its students in ... many innovations. An example of recently licensed university technology ... neuroscientists in the laboratory. Associate Professor Nasri Nesnas ... CDNI-Glu, a commonly used laboratory research tool. Most often, ...
... Multiple myeloma is one of the most common blood cancers, ... study from Uppsala University, researchers now present a conceptually new ... study was done in collaboration with Vrije Universitet Brussels and ... PLoS ONE . Using large cohorts of myeloma ...
Cached Medicine News:Health News:Breast cancer cells regulate multiple genes in response to estrogen-like compounds 2Health News:John Theurer Cancer Center first cancer center in N.J. to acquire new radiotherapy system 2Health News:John Theurer Cancer Center first cancer center in N.J. to acquire new radiotherapy system 3Health News:Battlefield psychologists investigate stress in combat and after 2Health News:Those To-Die-For High Heels May Alter Anatomy 2Health News:Those To-Die-For High Heels May Alter Anatomy 3
(Date:1/15/2014)... Jan. 15, 2014  Zafgen, Inc., a leading biopharmaceutical ... severely obese patients, today announced initial results from ... inhibitor of methionine aminopeptidase 2 (MetAP2), in patients ... genetic obesity.  These results showed improvements in body ...
(Date:1/14/2014)... 14, 2014 InformEx, North America,s ... chemistry, will hold the 30 th edition of its ... Convention Center from January 21-24. (Logo: http://photos.prnewswire.com/prnh/20131028/NY05330LOGO-a ... pharmaceutical, fine chemical and specialty chemical companies will take part ...
(Date:1/14/2014)... Animal Emergency Critical Care, a LifeCentre partner practice, located at 165 ... the first in Loudoun County to receive ... Susan M. Barnes , Medical Director, is a well-seasoned veterinarian of ... Taylor , are avid scuba divers. "As altitude skiers and hikers, ...
Breaking Medicine Technology:Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2Hyperbaric Veterinary Medicine (hvm) Announces Animal Emergency Critical Care Installs A Small Animal Hyperbaric Chamber 2
... March 8, 2012 , Quality of Life ... available treatment fails in two thirds of patients ... Pevion Biotech AG today announced results from a large, ... vulvovaginal candidiasis (RVVC) patients. It is the first time that ...
... Inc. (Nasdaq: BIOD ) today announced that ... will present a corporate update at the ROTH 24th Annual ... 3:00 p.m. Pacific Time (6:00 p.m. Eastern Time). ... Conference will be held March 11-14, 2012, at the ...
Cached Medicine Technology:Pevion Mandated Patient Survey Confirms Disease Burden of Recurrent Vulvovaginal Candidiasis (RVVC) and Indicates Public Health Problem 2Pevion Mandated Patient Survey Confirms Disease Burden of Recurrent Vulvovaginal Candidiasis (RVVC) and Indicates Public Health Problem 3Pevion Mandated Patient Survey Confirms Disease Burden of Recurrent Vulvovaginal Candidiasis (RVVC) and Indicates Public Health Problem 4
... allows braided suture to be used in ... may be used with any type or ... with anchors or screws (including suture pre-assembled ... Relay can be passed through any conventional ...
The 4mm diameter Revo suture anchor is designed primarily for arthroscopic and open rotator cuff repair. Additional applications include other shoulder repair procedures, as well as use in knees and ...
... sutureless fixation device offers superior fixation ... implant firmly reattaches soft tissue to ... CuffTack is indicated for the fixation ... to bone. The implant is composed ...
... to use system can be used for ... is pre-packaged on a sterile disposable inserter. ... simple and reproducible insertion of the anchor ... (I.S.S.™) Eyelet Design allows for the two ...
Medicine Products: